Key Takeaways
- Soft quarter, weather-driven: Revenue fell 9.2% YoY as erratic monsoon rains disrupted paddy sowing and suppressed Pretilachlor demand, while a one-time export receivable write-off and pre-incurred job work charges compounded the margin hit.
- Margins compressed but defended: EBITDA margin dropped to 15.4% from 18.4% YoY; management calls ~15.5% sustainable and sees a path back to ~18% if geopolitical conditions improve.
- EU approval unlocks direct exports: Technical Equivalence approval for one fungicide lets IPL sell directly into Europe rather than through a single customer, with ₹30–40 crores of incremental revenue expected from November.
- Capacity story intact: Hamirpur and Sandila each carry a ₹1,000 crore four-year revenue ambition, funded entirely through internal accruals with no term debt.
- What to watch next quarter: Whether Q2 stays subdued as management flagged, whether inventory days fall toward 170 in Q3 as intermediates get consumed, and whether the new China-substitute fungicide gains visible traction.
Quarterly Performance
- Revenue decline: Q1 FY27 revenue fell 9.2% YoY, driven by a ~13% volume decline partially offset by a ~4% price rise.
- Domestic demand: Deficient and erratic rainfall across India delayed or destroyed paddy sowing, directly hitting demand for Pretilachlor, IPL's key herbicide.
- Export stability: Export contribution held at approximately 35% of total revenue, with Q1 exports slightly better than last year's Q1.
- Margin walk: EBITDA margin fell from 18.4% to 15.4% YoY on lower sales volume, higher employee costs, and increased fuel expenses.
- One-off write-off: Other expenses included a one-time write-off of export receivables of ₹2.5 crores.
- Job work timing mismatch: IPL incurred ~₹6 crores of higher job work charges converting raw material into intermediates in anticipation of strong Q1 sales; June sales declined but the cost was already sunk. The intermediates are expected to be consumed in Q3 when the season starts.
- Inventory build: Inventory days rose from 170 to 200 because IPL manufactured in anticipation of good Q1 demand that did not materialize; receivables remained stable.
- Raw material and finished goods prices: Both raw material prices and finished goods prices have moderated.
D. K. Jain: "See, this quarter we could get 15.5% and we feel that this is sustainable though we would like to increase. We agree the quarter is slightly subdued, but otherwise we had expected EBITDA of about 18%. As the overall geopolitical situation improves, we feel our margins will also improve."
Pretilachlor & Monsoon Impact
- Demand subdued: Pretilachlor demand was slightly subdued this year because of irregular rains across the country; heavy rain damaged crops in some areas while rainfall shortfall delayed or destroyed sowing elsewhere.
- Volume impact: One major paddy-used product saw reduced sales due to erratic rains, pulling volumes down and slowing Q1 margins.
- Current quarter caution: Management flagged that the current quarter may be subdued, with some improvement expected in future; long-term strategy remains intact.
- Product dependence: IPL is working to add more molecules to its portfolio to reduce dependence on any single molecule.
D. K. Jain: "Pretilachlor will remain very good product for paddy and we hope that we are the major player in this field and we will continue to do so."
New Products & EU Approval
- EU Technical Equivalence: IPL received Technical Equivalence approval from the European Union for one fungicide product during the quarter, an important step in its global expansion strategy that enhances access to the European market.
- Direct EU access: Previously IPL operated through one customer in Europe; with the approval it can now operate directly and add new customers.
- Incremental EU revenue: Additional revenue of ₹30–40 crores is expected from the TEQ molecule, with sales commencing most probably from November onwards; customers need 1–2 months to add IPL as a source after equivalency.
- China-substitute fungicide: IPL has started manufacturing small quantities of a fungicide widely used in mixtures that is primarily imported from China; no major Indian manufacturer exists today, and IPL will become the major producer in India.
- Fungicide economics: The product will be produced at the Sandila facility using an existing plant with ₹2–3 crores of balancing equipment; it is made from basic level with ~3 stages, with starting material being an industrial chemical available in the market.
- Market target: IPL expects to capture at least 2,000 tons of the ~4,000–5,000 tons India import market; the product is primarily for domestic market, with a blend of ~50% domestic orientation and 50% export-exclusive products being targeted.
- Product name withheld: Management declined to name the new China fungicide product, saying they have already started manufacturing small quantity and are testing market position.
D. K. Jain: "As we understand, there is no major producer of this product in India. We will be the major producer now in India for this product and this will be produced at our Sandila facility."
Capacity Expansion: Hamirpur & Sandila
- Hamirpur progress: Development at the Hamirpur facility continues as planned with 2 out of 10 blocks currently operational.
- Hamirpur FY27 revenue: Hamirpur business is expected to generate around ₹50–60 crores this year, revised down from an earlier expectation of ₹70–80 crores.
- Hamirpur long-term: With 8–10 production blocks, IPL expects almost ₹1,000 crores turnover in the coming 4 years, installing 2 blocks every year for the coming 3–4 years.
- Sandila long-term: IPL expects at least ₹1,000 crores from Sandila in the coming 4 years; Block 1 is under commissioning, the herbicide block starts this financial year, and two more blocks will be added in 3 years.
- Herbicide complex priority: Work is already going on at Hamirpur; the priority is the herbicide block first, then the fungicide block.
- Multipurpose herbicide plant: IPL is building a multipurpose herbicide plant in the new subsidiary at Hamirpur that will produce 2 products simultaneously.
- Intermediate plant: An intermediate plant developed using in-house indigenous R&D technology supports supply chain stability and reduces dependence on imported intermediates.
- Capex run-rate: IPL continues to spend ₹70–100 crores per year at Hamirpur and ₹25–30 crores at Sandila for add-up systems, roughly ₹100 crores every year across both sites combined.
- Capex funding: The objective is not to take any term loan in India Pesticides for its expansion; capex will be funded through internal accruals only, supported by a healthy cash balance.
S. P. Gupta: "Our object has been not to take any term loan in India Pesticide for its expansion and we have already a very healthy cash balance. So we will be funding our capex through internal accruals only."
Margins, Working Capital & Competitive Position
- Margin sustainability: Q1 EBITDA margin of 15.5% is considered sustainable; management would like to increase it and sees ~18% as achievable if the geopolitical situation improves, with at least 15–16% sustainable in the near term.
- Long-term margin confidence: Management is confident of ~18% EBITDA margin in 2–3 years barring uncertainties.
- Working capital: Receivable days are expected to remain ~120; inventory days are expected to come down to ~170 in Q3 as intermediates get consumed.
- Cash flow: Receivables are coming on time; management is confident cash flow will be better.
- China competition: IPL is trying to improve operational efficiency and compete with Chinese imports; the R&D team is working regularly to optimize process conditions and engineering to reduce overall project cost.
- Shalvis consolidation: Only ~₹3 crores revenue came from Shalvis in Q1, knocked off in consolidation because raw material was sourced from India Pesticides.
D. K. Jain: "We are trying to improve our operational efficiency and trying to compete with Chinese imports and that is where our R&D team is working regularly to optimize further the process conditions and we are also optimizing in engineering to reduce the overall project cost."
Guidance & Commitments
| Commitment | Specifics | Timeline |
|---|---|---|
| FY27 top-line growth | Lower single-digit growth, with Q3 and Q4 expected to be better | FY27 |
| Hamirpur FY27 revenue | ₹50–60 crores | FY27 |
| Hamirpur long-term revenue | ~₹1,000 crores turnover, installing 2 blocks every year | Coming 3–4 years |
| Sandila long-term revenue | At least ₹1,000 crores, with 2 more blocks added | Coming 4 years |
| EU TEQ incremental revenue | ₹30–40 crores, sales commencing from November | November onwards |
| New fungicide market capture | At least 2,000 tons of ~4,000–5,000 tons India import market | No date |
| Inventory days | Come down to ~170 | Q3 FY27 |
| Receivable days | Remain ~120 | Ongoing |
| EBITDA margin | ~18% if geopolitical situation improves; at least 15–16% sustainable | 2–3 years for ~18% |
| Capex funding | No term loan; funded through internal accruals only | Ongoing |
Key Metrics
| Metric | Q1 FY27 |
|---|---|
| Revenue | ₹256 crores, down 9.2% YoY from ₹282 crores |
| EBITDA | ₹39 crores, down from ₹52 crores in Q1 FY26 |
| EBITDA margin | 15.4%, down from 18.4% in Q1 FY26 |
| PAT | ₹23 crores, down from ₹35 crores in Q1 FY26 |
| PAT margin | 8.9% |
| Export revenue | ₹89 crores, up from ₹87 crores in Q1 FY26; approximately 35% of total revenue |
| Domestic revenue | ₹167 crores, down from ₹195 crores in Q1 FY26 |
| Chemicals revenue | ₹181 crores |
| Formulations revenue | ₹72 crores |
| Volume decline | ~13%, offset by price rise of ~4% |
| FY27 revenue growth guidance | Lower single-digit growth expected |
| Capacity utilization | ~70% |
| Receivable days | ~120 days, expected to remain stable |
| Inventory days | ~200 days, up from 170 days; expected to normalize to ~170 days in Q3 |
| Cash balance | ₹59 crores as at 30th June |
| Hamirpur FY27 revenue expectation | ₹50–60 crores |
| Hamirpur long-term revenue potential | ~₹1,000 crores from 8–10 blocks, in 3–4 years |
| Sandila long-term revenue potential | At least ₹1,000 crores in coming 4 years |
| Combined annual capex (Sandila + Hamirpur) | ~₹100 crores every year |
| New fungicide product import substitution | 4,000–5,000 tons imported annually; IPL targeting at least 2,000 tons capacity |
| New fungicide product price | ₹500–600 per kg |
| EU TEQ approval incremental revenue | ₹30–40 crores additional, on top of existing ~₹100 crores annual revenue |
| One-time export receivable write-off | ₹2.5 crores |
| Increased job work charges | Higher by ~₹6 crores |